Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis: Investigating the potential effect and mechanism of brodalumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis: Investigating the potential effect and mechanism of brodalumab

Published:2024-06 Issue: Volume:178 Page:156587
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Matsuda Kazuki M.,Kotani Hirohito,Hisamoto Teruyoshi,Kuzumi Ai,Fukasawa Takemichi,Yoshizaki-Ogawa Asako,Sato Shinichi,Yoshizaki Ayumi

Funder

Okinaka Memorial Institute for Medical Research

Publisher

Elsevier BV

Reference53 articles.

1. Liver fibrosis;Bataller;J. Clin. Invest.,2005

2. Treatment of patients with cirrhosis;Ge;N. Engl. J. Med.,2016

3. Attributable risk estimate of severe psoriasis on major cardiovascular events;Mehta;Am. J. Med.,2011

4. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies;Armstrong;J. Am. Acad. Dermatol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP